Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Bactiguard Holding Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Bactiguard Holding wird ein jährliches Gewinn- und Umsatzwachstum von 94.3% bzw. 13.5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 94.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich -4.3% betragen.

Wichtige Informationen

94.3%

Wachstumsrate der Gewinne

94.2%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum	25.0%
Wachstumsrate der Einnahmen	13.5%
Zukünftige Eigenkapitalrendite	-4.3%
Analystenabdeckung	Low
Zuletzt aktualisiert	03 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Bactiguard Holding AB (publ)'s (STO:BACTI B) 30% Share Price Surge Not Quite Adding Up

Feb 06

Bactiguard Holding (STO:BACTI B) Is Carrying A Fair Bit Of Debt

Jan 12

Is Bactiguard Holding (STO:BACTI B) Using Debt In A Risky Way?

Jul 02

Bactiguard Holding AB (publ)'s (STO:BACTI B) Business Is Trailing The Industry But Its Shares Aren't

May 05

Gewinn- und Umsatzwachstumsprognosen

OM:BACTI B - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (SEK Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	306	47	39	75	1
12/31/2025	238	-23	1	37	2
12/31/2024	223	-59	-72	-36	1
3/31/2024	202	-126	-77	-64	N/A
12/31/2023	204	-138	-61	-52	N/A
9/30/2023	211	-125	-62	-55	N/A
6/30/2023	224	-109	-23	-11	N/A
3/31/2023	233	-58	-4	7	N/A
12/31/2022	227	-53	-8	3	N/A
9/30/2022	209	-64	-24	-16	N/A
6/30/2022	193	-66	-13	-11	N/A
3/31/2022	186	-65	-8	-4	N/A
12/31/2021	172	-59	0	7	N/A
9/30/2021	216	-44	10	23	N/A
6/30/2021	203	-50	-11	5	N/A
3/31/2021	170	-38	-14	3	N/A
12/31/2020	177	-38	-15	1	N/A
9/30/2020	155	-26	26	34	N/A
6/30/2020	187	14	55	61	N/A
3/31/2020	206	9	53	57	N/A
12/31/2019	190	16	50	54	N/A
9/30/2019	155	9	7	14	N/A
6/30/2019	128	-15	-10	-4	N/A
3/31/2019	149	-10	0	7	N/A
12/31/2018	150	-15	-5	1	N/A
9/30/2018	160	-10	-6	1	N/A
6/30/2018	159	-10	-4	3	N/A
3/31/2018	143	-15	-12	-5	N/A
12/31/2017	151	-3	N/A	6	N/A
9/30/2017	142	-10	N/A	-8	N/A
6/30/2017	142	-10	N/A	-14	N/A
3/31/2017	140	-12	N/A	-18	N/A
12/31/2016	124	-27	N/A	-12	N/A
9/30/2016	116	-39	N/A	-18	N/A
6/30/2016	139	-32	N/A	-6	N/A
3/31/2016	133	-34	N/A	-11	N/A
12/31/2015	135	-27	N/A	-21	N/A
9/30/2015	120	-39	N/A	-30	N/A
6/30/2015	87	-61	N/A	-60	N/A
3/31/2015	88	-95	N/A	-62	N/A
12/31/2014	95	-111	N/A	-36	N/A
9/30/2014	137	-60	N/A	-47	N/A
6/30/2014	143	-50	N/A	-28	N/A
3/31/2014	136	-20	N/A	-25	N/A
12/31/2013	129	-3	N/A	-45	N/A
9/30/2013	110	-20	N/A	-54	N/A
6/30/2013	104	-32	N/A	-54	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: BACTI B wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: BACTI B wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: BACTI B wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: BACTI BDie Einnahmen des Unternehmens (13.5% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swedish (2.1% pro Jahr).

Hohe Wachstumseinnahmen: BACTI BDie Einnahmen des Unternehmens (13.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: BACTI B wird voraussichtlich in 3 Jahren unrentabel sein.

Bactiguard Holding Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Forecast to breakeven in 2026

Forecast to breakeven in 2026

Recent updates

Director recently bought kr129m worth of stock

Bactiguard Holding Ab Appoints Thomas Von Koch as the Chairman of the Board of Directors

Forecast to breakeven in 2026

Director recently bought kr6.8m worth of stock

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Forecast to breakeven in 2026

Bactiguard Holding AB (publ.) Announces CEO Changes as of 12 April 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Christian Kinch Declines Re-Election as Board Member of Bactiguard Holding AB (publ)

Interim CEO & Director recently bought kr13m worth of stock

New minor risk - Share price stability

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Bactiguard Announces CEO Changes

Bactiguard Holding AB (publ)'s (STO:BACTI B) 30% Share Price Surge Not Quite Adding Up

Bactiguard Holding (STO:BACTI B) Is Carrying A Fair Bit Of Debt

Bactiguard Holding AB (Publ) Announces Executive Changes

Interim CEO & Director recently bought kr9.1m worth of stock

Bactiguard Holding AB (publ), Annual General Meeting, May 14, 2024

Third quarter 2023 earnings released

Bactiguard Holding AB (publ) to Report Q1, 2024 Results on Apr 25, 2024

Bactiguard Announces Publishing of New Study

Second quarter 2023 earnings released

Is Bactiguard Holding (STO:BACTI B) Using Debt In A Risky Way?

New minor risk - Share price stability

Bactiguard Holding AB (Publ) Announces CEO Changes

Bactiguard Holding AB (Publ) Elects Rick Kuntz as Member of the Board

Independent Chairman of the Board recently bought kr24m worth of stock

Bactiguard Holding AB (publ)'s (STO:BACTI B) Business Is Trailing The Industry But Its Shares Aren't

Full year 2022 earnings released: kr1.51 loss per share (vs kr1.68 loss in FY 2021)

Bactiguard Holding (STO:BACTI B) Has Debt But No Earnings; Should You Worry?

Full year 2022 earnings released: kr1.51 loss per share (vs kr1.68 loss in FY 2021)

Bactiguard Holding AB (publ) to Report Fiscal Year 2022 Results on Feb 09, 2023

Bactiguard Holding AB (Publ) Receives First MDR Product Approval

Bactiguard Holding AB (publ) Announces Nomination Committee Appointments

Third quarter 2022 earnings released

Bactiguard Holding AB (publ) to Report Fiscal Year 2022 Results on Apr 05, 2023

Does Bactiguard Holding (STO:BACTI B) Have A Healthy Balance Sheet?

Second quarter 2022 earnings released

Bactiguard Announces European Patent Office Intends to Grant A European Patent for Bactiguard's Infection Prevention Technology

Independent Director recently bought kr2.7m worth of stock

Independent Director recently bought kr6.1m worth of stock

Is Bactiguard Holding (STO:BACTI B) Using Debt Sensibly?

Bactiguard Holding AB (publ) Elects Magdalena Persson as New Member of the Board

First quarter 2022 earnings: Revenues in line with analyst expectations

Full year 2021 earnings: EPS misses analyst expectations

Full year 2021 earnings: EPS exceeds analyst expectations

Does Bactiguard Holding (STO:BACTI B) Have A Healthy Balance Sheet?

Third quarter 2021 earnings released

First quarter 2021 earnings released: kr0.31 loss per share (vs kr0.34 loss in 1Q 2020)

Full year 2020 earnings released: kr1.14 loss per share (vs kr0.49 profit in FY 2019)

New 90-day high: kr162

Is Bactiguard Holding (STO:BACTI B) Using Too Much Debt?

Bactiguard Holding AB (publ) Announces Health Canada Provides COVID-19 Interim Order Approval for Bactiguard's Tempsensor Catheter

Full year 2020 earnings released

New 90-day high: kr160

Bactiguard Holding AB (publ) Announces Resignation of Cecilia Edström as Chief Executive Officer

Bactiguard Holding AB (publ) to Report Fiscal Year 2020 Results on Feb 04, 2021

Bactiguard Recruits Peter Rådqvist as Global Head of Sales, Effective 1 February 2021

Do Institutions Own Bactiguard Holding AB (publ) (STO:BACTI B) Shares?

Bactiguard Enters into A New Partnership with Lifecyn S.A. in Greece

Did Bactiguard Holding AB (publ) (STO:BACTI B) Insiders Buy Up More Shares?

New 90-day low: kr142

Bactiguard Holding (STO:BACTI B) Has A Pretty Healthy Balance Sheet

New 90-day low: kr160

Bactiguard Holding AB (publ) Appoints Petra Kaur Ljungma as Chief Marketing and Communications Officer

New 90-day high - kr194

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken